Jenn Abelin, Ph.D.

Jenn Abelin is a senior group leader in the Proteomics Platform at the Broad Institute of MIT and Harvard, where she works under the guidance of Steven Carr. Abelin works within a highly matrixed team where she enjoys mentoring early career technical scientists who are developing mass spectrometry technologies that aid in the study of HLA antigen processing and presentation and immunological pathways across different disease states including cancer, infectious disease, and autoimmunity.

Prior to rejoining the Broad Institute in 2019, Abelin held an associate director position in the biotech Industry at Neon Therapeutics, a role she advanced into from 2016 to 2019. From 2013 to 2016, Abelin was a postdoctoral fellow and instructor in the Proteomics Platform.  

Abelin received her B.Sc. from Guilford College in biology and chemistry (2009) and her Ph.D. from the University of Virginia (2012).